The reaction between a specific antibody and antigen results in visible clumping is called agglutination. The test used to analyze the variation on the clumping ability of the antigen when it reacted with an antibody placed on the surface of latex particles is called latex agglutination test. The agglutination reaction may also be reversed, the use of systematic beads provide the advantages and consistency, uniformity, and stability. Moreover, the latex agglutination assay gives rapid advantage for quick results within a shorter period of time. Additionally, latex agglutination test provides the versatility of the reaction, simple design and ability to work in small quantity of the sample. Among the multiple diseases, the test mostly used for the serological diagnosis of rheumatoid arthritis. However, the latex agglutination principle also used in the diagnosis of infections like Hepatitis B, H.influenzae, N. meningitidis, etc.
Latex agglutination test market anticipated growth in the forecast period with rising patent pool suffering from rheumatoid arthritis, anticipated to grow over the forecast period. The effectiveness of the testing outcome is the major driver for the latex agglutination test market. However, the latex agglutination test also applied to the diagnosis of the autoimmune disorder and Hepatitis B infections, since the increasing the Hepatitis B infection to the children’s expected to boost the latex agglutination test market in future. Regional government authorities have more concern to provide the treatment for the infectious disease like hepatitis B. Since, the flexible regional government policies expected to fuel the latex agglutination test market in the future. Rising demand for point-of-care services is expected to drive the latex agglutination test market during the forecast period. Point-of-care services provide accurate results in a shorter period of time compared to traditional methods. Less awareness of the people about the test may restrain the latex agglutination test market in the future. Vaccination program for the infectious disease expected to cause slowdown growth of latex agglutination test system market.
The global latex agglutination test system market is classified on the basis of test type, product type, disease type, end user and region.
Based test type, Latex Agglutination Test market is segmented into the following:
Based product type, Latex Agglutination Test market is segmented into the following:
Based on end user Latex Agglutination Test market is segmented into the following:
From the test type segment, latex agglutination test for antigen expected to boost the demand of the latex agglutination test market as compared to the latex agglutination test for antibody detection test, Due to the rising prevalence of the opportunistic disease like H. influenza, Streptococcus species etc. based on the product type ELISA is most common test used for the antigen and antibody detection in serological test, over the forecast period ELISA test anticipated to increase in demand for latex agglutination test market in future. Indirect fluorescent antibody test and hemagglutination – inhibition test market may show the slower growth in the latex agglutination test market due to less awareness and popularity among the people. Among the end user market hospitals are expected to show lucrative growth as compared to the diagnostic center for the latex agglutination test market.
Among the regional presence, Geographically, North America anticipated being the leading region globally during the forecast period. The high adoption rate of diagnosis device and the accessibility of advanced techniques for diagnosis are the two major factors for high market share in the region. Europe region expected to show the second dominating market for latex agglutination test, since the increasing demand for the novel diagnostic methods for the infectious diseases and people preferring the invasive techniques for the diagnosis as compared to the traditional methods. Hence, in coming years latex agglutination test may take good stand in Europe region. However, due to the high prevalence of infectious disease rate India and China is the key factor behind the robust the growth of latex agglutination test market in South Asia and East Asia region. The Middle East and Africa are expected to account for being the least lucrative market for latex agglutination test due to lack of technology advancement and good diagnostic methods.
Some of the key players across the value chain of latex agglutination test market are Thermo Fisher Scientific, Biocompare, Biotec, HiMedia Laboratories, bioMérieux SA, Hardy Diagnostics, Microbiology International, Creative Diagnostics, Biotium, BioLegend, Inc.and others.
The report on Latex Agglutination Test market covers exhaustive analysis on:
Regional analysis for on Latex Agglutination Test market includes
Report on Latex Agglutination Test market highlights: